|
|
Crystalgenomics Incorporation - Comparative Business Analysis Snapshot
Business Description
Crystalgenomics Incorporation. The Group's principal activity is providing biotechnology services. The Company has two main businesses: new drug development and structure determination research. Its new drug development business is involved in the development of anti-cancer remedies, antibiotics, remedies for glycosuria and hypoxia diseases, and obesity treatment medicines. Its structure determination research business mainly provides three dimensional structure determination services.
Competitor Analysis
This analysis compares Crystalgenomics Incorporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
